|
|
Office Locations:
|
26 White Pine Canyon Rd.
Park City, UT 84060-6508
Phone: 435-649-9948
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Numenor Ventures is a Utah based investment management company that oversees investments in private life sciences companies. Numenor also provides consulting services to CEOs and company founders. As of January 2009, the firm is no longer making new investments and is instead focusing on existing portfolio companies. R. Scott Greer, the managing director of Numenor, is a private investor in, and consultant to, the biotechnology industry (with over twenty years experience). He is a founder of Abgenix, Inc., a biotechnology company focused on developing and commercializing human antibody based therapeutics.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
